Real-time enrollment status for this lung non-small cell carcinoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 8:21 PM UTC
| NCT Number | NCT06225427 |
| Recruiting Status | Recruiting |
| Condition | Lung Non-Small Cell Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 3 sites in the US |
| Sponsor | University of Michigan Rogel Cancer Center |
| Last Updated on CT.gov | June 26, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT06225427 is currently recruiting participants. This phase1 study for lung non-small cell carcinoma is actively seeking new participants at 3 locations across the United States. The study is sponsored by University of Michigan Rogel Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06225427 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06225427 was last updated 3 weeks ago (June 26, 2026). HelloStudys verifies this status automatically.